Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European Americans

Journal of Medical Genetics

Volumn 43, Issue 12, 2006, Pages 917-923

  Chretien, J P ^b   Coresh, J ^a,b   Berthier Schaad, Y ^b   Kao, W H L ^b   Fink, N E ^b   Klag, M J ^b   Marcovina, S M ^c   Giaculli, F ^c   Smith, M W ^d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; ISOPROTEIN; LIPOPROTEIN A;

AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EUROPEAN AMERICAN; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN VARIANT; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ALLELES; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; HUMANS; KIDNEY FAILURE, CHRONIC; LINKAGE DISEQUILIBRIUM; LIPOPROTEIN(A); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 33846168084     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2006.042119     Document Type: Article

References (38)

1. Rosenberg NA, Prtichard JK, Weber JL, et al. Genetic structure of human populations. Science 2002;298:2381-5.
2. Carlson CS, Eberle MA, Rieder MJ, et al. Additional SNPs and linkage-disequilibrium analyses are necessary for whole-genome association studies in humans. Nat Genet 2003;33:518-21.
3. Risch N, Burchard E, Ziv E, et al. Categorization of humans in biomedical research: genes, race and disease. Genome Biol 2002;3:comment2007.
4. Cordell HJ, Clayton DG. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/ control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 2002;70:124-41.
5. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001;17:502-10.
6. Kraft HG, Lingenhel A, Pang RW, et al. Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random. Eur J Hum Genet 1996;4:74-87.
7. Marcovina SM, Albers JJ, Wijsman E, et al. Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. J Lipid Res 1996;37:2569-85.
8. Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation 2000;102:1082-5.
9. Tsimikas S, Brilakis ES, Miller ER, et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 2005;353:46-57.
10. Scanu AM. Lipoprotein(a). Link between structure and pathology. Ann Epidemiol 1992;2:407-12.
11. Edelberg JM, Gonzalez-Gronow M, Pizzo SV. Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator. Thromb Res 1990;57:155-62.
12. Boerwinkle E, Leffert CC, Lin J, et al. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992;90:52-60.
13. Mooser V, Scheer D, Marcovina SM, et al. The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans. Am J Hum Genet 1997;61:402-17.
14. Prins J, Leus FR, Bouma BN, et al. The identification of polymorphisms in the coding region of the apolipoprotein (a) gene-association with earlier identified polymorphic sites and influence on the lipoprotein (a) concentration. Thromb Haemost 1999;82:1709-17.
15. Brunner C, Lobentanz E-M, Petho-Schramm A, et al. The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells. J Biol Chem 1996;271: 32403-10.
16. Mooser V, Mancini FP, Bopp S, et al. Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum Mol Genet 1995;4:173-81.
17. Ogorelkova M, Gruber A, Utermann G. Molecular basis of congenital lp(a) deficiency: a frequent apo(a) 'null' mutation in caucasians. Hum Mol Genet 1999;8:2087-96.
18. Ogorelkova M, Kraft HG, Ehnholm C, et al. Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians. Hum Mol Genet 2001;10:815-24.
19. Puckey LH, Lawn RM, Knight BL. Polymorphisms in the apolipoprotein(a) gene and their relationship to allele size and plasma lipoprotein(a) concentration. Hum Mol Genet 1997;6:1099-107.
20. Trommsdorff M, Kochl S, Lingenhel A, et al. A pentanucleotide repeat polymorphism in the 5′ control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J Clin Invest 1995;96:150-7.
21. Kraft HG, Windegger M, Menzel HJ, et al. Significant impact of the +93 C/T polymorphism in the apolipoprotein(a) gene on Lp(a) concentrations in Africans but not in Caucasians: confounding effect of linkage disequilibrium. Hum Mol Genet 1998;7:257-64.
22. Scholz M, Kraft HG, Lingenhel A, et al. Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians. Eur J Hum Genet 1999;7:169-78.
23. Rotimi CN, et al. Serum distribution of lipoprotein(a) in African Americans and Nigerians: potential evidence for a genotype-environmental effect. Genet Epidemiol 1997;14:157-68.
24. Powe NR, Klag MJ, Sadler JH, et al. Choices for healthy outcomes in caring for end stage renal disease. Semin Dial 1996;9:9-11.
25. Astor BC, Eustace JA, Klag MJ, et al. Race-specific association of lipoprotein(a) with vascular access interventions in hemodialysis patients: the CHOICE Study. Kidney Int 2002;61:1115-23.
26. Underhill PA, Jin L, Lin AA, et al. Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. Genome Res 1997;7:996-1005.
27. Yang Z, Boffelli D, Boonmark N, et al. Apolipoprotein(a) gene enhancer resides within a LINE element. J Biol Chem 1998;273:891-7.
28. Lindblad-Toh K, Winchester E, Daly MJ, et al. Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse. Nat Genet 2000;24:381-6.
29. Arlequin Version 2. A software for population genetics data analysis, Genetics and Biometry Laboratory, Switzerland: University of Geneva, 2000.
30. Kronenberg F, Konig P, Neyer U, et al. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995;6:110-20.
31. Longenecker JC, Klag MJ, Marcovina SM, et al. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients. J Am Soc Nephrol 2005;16:1794-802.
32. Brazier L, Tiret L, Luc G, et al. Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study. Atherosclerosis 1999;144:323-33.
33. Burchard EG, Ziv E, Coyle N, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 2003;348:1170-5.
34. Chakravarti A. Population genetics-making sense out of sequence. Nat Genet 1999;21(Suppl 1):56-60.
35. Suzuki K, Kuriyama M, Saito T, et al. Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5′-flanking region. J Clin Invest 1997;99:1361-6.
36. Gabel BR, Koschinsky ML. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100. Biochemistry 1998;37:7892-8.
37. Prins J, Leus FR, van der Hoek YY, et al. The identification and significance of a Thr→Pro polymorphism in kringle IV type 8 of apolipoprotein(a). Thromb Haemost 1997;77:949-54.
38. Zysow BR, Lindahl GE, Wade DP, et al. C/T polymorphism in the 5′ untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler Thromb Vasc Biol 1995;15:58-64.